Thu, Dec 18, 2014, 12:05 AM EST - U.S. Markets open in 9 hrs 25 mins


% | $
Quotes you view appear here for quick access.

MannKind Corp. Message Board

  • howcomethisdoesnotwork howcomethisdoesnotwork Aug 1, 2013 10:47 AM Flag

    $20-$100 a share by 2015, hence $30-$50 good price to pull out

    $20-$100 a share by 2015, hence $30-$50 good price to pull out

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Treatments for one of the biggest problems in medicine do not turn on a dime. Clearly the pumpers do not operate in that world. Our reputations in the business are built on long term treatment results with large numbers of patients. Switching to something like this is disruptive to your whole approach to tx, and keep in mind most patients are complex with comorbidities. Caution and prudence dictate approaches to treatments. A lot of MD's will not just up and Rx new drugs just getting approval unless there are not alternatives. They wait for the first year or so to let the 'Phase lV' trial as it were to play out in the real world.
      Afrezza will have its day, month and years to be sure. 2014 or 2015 will not be it though.
      But by 5 years with new MD's in practice and experienced ones having time with this. Well then, the sky is the limit.
      Patience will reward you here.

      Sentiment: Strong Buy

    • IMO, it will take at least a couple of years for market dynamics to change and for MNKD to reach share prices above $20 or 30. 2015 is too soon.

      If there is a paradigm shift in T2 diabetic treatment (and I hope and believe there will be), then it would not be smart to sell any shares below $50 anytime soon. That is my line of thought, and has been for a long time.

5.19+0.090(+1.76%)Dec 17 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.